FDA NDC Directory · JSON-LD · Markdown

ESOMEPRAZOLE MAGNESIUM

NDC 69097-527 · HUMAN PRESCRIPTION DRUG · GRANULE, FOR SUSPENSION, EXTENDED RELEASE

Labeler / ManufacturerCipla USA Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA211752
Dosage form / routeGRANULE, FOR SUSPENSION, EXTENDED RELEASE · ORAL
Active ingredientsESOMEPRAZOLE MAGNESIUM (10 mg/1)
Marketing started20200324
Package count1

External sources

Source: openFDA. Public-domain (CC0).